Tezted, a diagnostics company in Jyväskylä, Finland, has developed an all-in-one Borrelia test that detects the three main Borrelia species — Borrelia afzelii, Borrelia burgdorferi, and Borrelia garinii — in their spirochetal and round-body persister forms.
To address the problem of Lyme co-infections, they also offer TickPlex Plus, which detects the Borrelias listed above and Babesia microti, Bartonella henselae, Ehrlichia chaffensis, and Rickettsia akari. It also screens for the opportunistic infections of Coxsackievirus, Epstein-Barr virus, Human Parvovirus B19, Mycoplasma fermentans, and Mycoplasma pneumoniae.
These tests use an indirect, enzyme linked immunosorbent assay (ELISA) antibody approach that has been validated using 432 characterized tick-borne disease specimens. (Garg et al. 2018). Their tests can be ordered in the U.S. through ArminLabs in Germany or Sanoviv Medical Institute in Mexico. The company is currently applying for FDA approval.
Tezted is a participant in Invisible International’s “Tick-borne Illness Diagnostics Development Incubator,” a yearlong collaborative forum designed to help bring better diagnostics solutions to the market faster.
Read more
https://arminlabs.com/en/tests/tickplex
|